Structure and biological activities of calcitonin and procalcitonin amino-terminal cleavage peptide

13301甲第4634号博士（理学）金沢大学博士論文要旨Abstract 以下に掲載：Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 211 pp.77-83 2017. Elsevier. 共著者：Yoichi Kase, Takahiro Ikari, Toshio Sekiguchi, Masayuki Sato, Shouzo Ogiso, Tsuyoshi Kawada, Shin Matsubara, Honoo Satake, Yuichi Sasayama, Masato Endo, Kei-ichiro Kitamura, Atsuhiko Hattori, Takushi X. Watanabe, Yusuke Maruyama, Yoshinari Watanabe, Hisayuki Funahashi, Akira Kambegawa, Nobuo Suzuk

Structure and biological activities of calcitonin and procalcitonin amino-terminal cleavage peptide

13301甲第4634号博士（理学）金沢大学博士論文本文Full 以下に掲載：Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 211 pp.77-83 2017. Elsevier. 共著者：Yoichi Kase, Takahiro Ikari, Toshio Sekiguchi, Masayuki Sato, Shouzo Ogiso, Tsuyoshi Kawada, Shin Matsubara, Honoo Satake, Yuichi Sasayama, Masato Endo, Kei-ichiro Kitamura, Atsuhiko Hattori, Takushi X. Watanabe, Yusuke Maruyama, Yoshinari Watanabe, Hisayuki Funahashi, Akira Kambegawa, Nobuo Suzuk

A novel laser melting sampler for discrete, sub-centimeter depth-resolved analyses of stable water isotopes in ice cores

We developed a novel laser melting sampler (LMS) for ice cores to measure the stable water isotope ratios (δ18O and δD) as temperature proxies at sub-centimeter depth resolutions. In this LMS system, a 2 mm diameter movable evacuation nozzle holds an optical fiber through which a laser beam irradiates the ice core. The movable nozzle intrudes into the ice core, the laser radiation meanwhile melts the ice cylindrically, and the meltwater is pumped away simultaneously through the same nozzle and transferred to a vial for analysis. To avoid isotopic fractionation of the ice through vaporization, the laser power is adjusted to ensure that the temperature of the meltwater is always kept well below its boiling point. A segment of a Dome Fuji shallow ice core (Antarctica), using the LMS, was then demonstrated to have been discretely sampled with a depth resolution as small as 3 mm: subsequent analysis of δ18O, δD, and deuterium excess (d) was consistent with results obtained by hand segmentation within measurement uncertainties. With system software to control sampling resolution, the LMS will enable us to identify temperature variations that may be detectable only at sub-centimeter resolutions in ice cores

Sardine procalcitonin amino-terminal cleavage peptide has a different action from calcitonin and promotes osteoblastic activity in the scales of goldfish

The nucleotide sequence of a sardine preprocalcitonin precursor has been determined from their ultimobranchial glands in the present study. From our analysis of this sequence, we found that sardine procalcitonin was composed of procalcitonin amino-terminal cleavage peptide (N-proCT) (53 amino acids), CT (32 amino acids), and procalcitonin carboxyl-terminal cleavage peptide (C-proCT) (18 amino acids). As compared with C-proCT, N-proCT has been highly conserved among teleosts, reptiles, and birds, which suggests that N-proCT has some bioactivities. Therefore, both sardine N-proCT and sardine CT were synthesized, and their bioactivities for osteoblasts and osteoclasts were examined using our assay system with goldfish scales that consisted of osteoblasts and osteoclasts. As a result, sardine N-proCT (10− 7 M) activated osteoblastic marker enzyme activity, while sardine CT did not change. On the other hand, sardine CT (10− 9 to 10− 7 M) suppressed osteoclastic marker enzyme activity, although sardine N-proCT did not influence enzyme activity. Furthermore, the mRNA expressions of osteoblastic markers such as type 1 collagen and osteocalcin were also promoted by sardine N-proCT (10− 7 M) treatment; however, sardine CT did not influence their expressions. The osteoblastic effects of N-proCT lack agreement. In the present study, we can evaluate exactly the action for osteoblasts because our scale assay system is very sensitive and it is a co-culture system for osteoblasts and osteoclasts with calcified bone matrix. Both CT and N-proCT seem to influence osteoblasts and osteoclasts and promote bone formation by different actions in teleosts. © 2017 Elsevier Inc.Embargo Period 12 month

Early-phase changes of extravascular lung water index as a prognostic indicator in acute respiratory distress syndrome patients

Background: The features of early-phase acute respiratory distress syndrome (ARDS) are leakage of fluid into the extravascular space and impairment of its reabsorption, resulting in extravascular lung water (EVLW) accumulation. The current study aimed to identify how the initial EVLW values and their change were associated with mortality. Methods: This was a post hoc analysis of the PiCCO Pulmonary Edema Study, a multicenter prospective cohort study that included 23 institutions. Single-indicator transpulmonary thermodilution-derived EVLW index (EVLWi) and conventional prognostic factors were prospectively collected over 48 h after enrollment. Associations between 28-day mortality and each variable including initial (on day 0), mean, maximum, and Δ (subtracting day 2 from day 0) EVLWi were evaluated. Results: We evaluated 192 ARDS patients (median age, 69 years (quartile, 24 years); Sequential Organ Failure Assessment (SOFA) score on admission, 10 (5); all-cause 28-day mortality, 31%). Although no significant differences were found in initial, mean, or maximum EVLWi, Δ-EVLWi was significantly higher (i.e., more reduction in EVLWi) in survivors than in non-survivors (3.0 vs. ?0.3 mL/kg, p = 0.006). Age, maximum, and Δ-SOFA scores and Δ-EVLW were the independent predictors for survival according to the Cox proportional hazard model. Patients with Δ-EVLWi > 2.8 had a significantly higher incidence of survival than those with Δ-EVLWi ? 2.8 (log-rank test, χ2 = 7.08, p = 0.008). Conclusions: Decrease in EVLWi during the first 48 h of ARDS may be associated with 28-day survival. Serial EVLWi measurements may be useful for understanding the pathophysiologic conditions in ARDS patients. A large multination confirmative trial is required